Important Dates
Early Bird Registration :21st February 2027
Paper Submission Deadline :26th February 2027
Last Date of Registration : 8th March 2027
Date of Conference : 23rd - 24th March 2027
Conference Session Tracks
Aligned with
UN Sustainable Development Goals
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals.
SDG 3 — Good Health and Well-being
SDG 4 — Quality Education
SDG 9 — Industry, Innovation and Infrastructure
Track 01
Molecular Mechanisms of Diabetes Pathogenesis
This track focuses on the intricate molecular pathways involved in the development of diabetes. It aims to elucidate the roles of genetic and epigenetic factors in the pathophysiology of the disease.
Track 02
Biomarkers in Diabetes Diagnosis and Management
This session will explore the latest advancements in identifying and validating biomarkers for diabetes. Emphasis will be placed on their potential to enhance early diagnosis and personalized treatment strategies.
Track 03
Insulin Resistance: Mechanisms and Therapeutic Approaches
This track will delve into the underlying mechanisms of insulin resistance and its implications for diabetes management. Discussions will include novel therapeutic approaches aimed at improving insulin sensitivity.
Track 04
Pancreatic Beta Cell Function and Dysfunction
This session will investigate the role of pancreatic beta cells in glucose homeostasis and their dysfunction in diabetes. Research on regenerative strategies and beta cell preservation will also be highlighted.
Track 05
Advances in Glucose Metabolism Research
This track will cover recent findings in glucose metabolism and its dysregulation in diabetes. The focus will be on metabolic pathways and their implications for therapeutic interventions.
Track 06
Genetic Insights into Diabetes Susceptibility
This session will present cutting-edge research on the genetic factors contributing to diabetes susceptibility. Discussions will include genome-wide association studies and their implications for risk assessment.
Track 07
Diabetic Complications: Mechanisms and Management
This track will address the pathophysiological mechanisms underlying diabetic complications. It will also explore innovative management strategies to mitigate these complications.
Track 08
Inflammation and Oxidative Stress in Diabetes
This session will examine the roles of inflammation and oxidative stress in the development and progression of diabetes. Research on anti-inflammatory and antioxidant therapies will be discussed.
Track 09
Clinical Research in Diabetes: Innovations and Challenges
This track will highlight recent clinical research findings in diabetes, focusing on innovative trial designs and methodologies. Challenges in translating research into clinical practice will also be addressed.
Track 10
Pharmacological Advances in Diabetes Treatment
This session will explore the latest pharmacological interventions for diabetes management. Emphasis will be placed on novel drug classes and their mechanisms of action.
Track 11
Epidemiology of Diabetes: Trends and Public Health Implications
This track will focus on the epidemiological trends of diabetes globally and their public health implications. Discussions will include strategies for prevention and health promotion in at-risk populations.